Latest news
Did Stronger Q2 Earnings and Lowered 2026 Guidance Just Recast Exelixis' (EXEL) Oncology Narrative? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 18:39:21 GMT17 Books Oncologists Recommend for Summer 2026 - Oncology News CentralOncology News Central · Wed, 05 Aug 2026 00:00:00 GMTHow Investors May Respond To Gilead Sciences (GILD) EMA Backing Trodelvy Plus Keytruda In First-Line TNBC - webull.comwebull.com · Fri, 31 Jul 2026 21:36:45 GMT